Q3 2022 Earnings Estimate for Cross Country Healthcare, Inc. (NASDAQ:CCRN) Issued By Oppenheimer

Cross Country Healthcare, Inc. (NASDAQ:CCRNGet Rating) – Equities researchers at Oppenheimer increased their Q3 2022 earnings per share estimates for shares of Cross Country Healthcare in a report released on Wednesday, September 14th. Oppenheimer analyst M. Wiederhorn now forecasts that the business services provider will earn $0.96 per share for the quarter, up from their prior estimate of $0.91. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $4.75 per share. Oppenheimer also issued estimates for Cross Country Healthcare’s Q4 2022 earnings at $0.82 EPS, FY2022 earnings at $4.89 EPS, Q1 2023 earnings at $0.76 EPS, Q2 2023 earnings at $0.81 EPS, Q3 2023 earnings at $0.79 EPS, FY2023 earnings at $3.17 EPS and FY2024 earnings at $3.38 EPS.

Other equities research analysts have also issued research reports about the company. Credit Suisse Group cut their price target on Cross Country Healthcare from $28.00 to $26.00 and set a “neutral” rating for the company in a research note on Thursday, June 9th. Benchmark increased their price objective on shares of Cross Country Healthcare from $37.00 to $42.00 and gave the company a “buy” rating in a report on Thursday. Finally, Barrington Research dropped their price objective on shares of Cross Country Healthcare to $40.00 in a report on Monday, August 22nd. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.75.

Cross Country Healthcare Trading Up 1.1 %

Shares of CCRN stock opened at $29.62 on Monday. Cross Country Healthcare has a 52-week low of $15.26 and a 52-week high of $30.51. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.67 and a current ratio of 2.67. The firm has a market capitalization of $1.13 billion, a PE ratio of 5.18, a PEG ratio of 0.63 and a beta of 1.03. The stock has a fifty day simple moving average of $25.56 and a two-hundred day simple moving average of $21.63.

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, Director W Larry Cash purchased 1,500 shares of the stock in a transaction that occurred on Tuesday, August 30th. The stock was purchased at an average price of $25.60 per share, with a total value of $38,400.00. Following the acquisition, the director now owns 177,899 shares in the company, valued at $4,554,214.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Cross Country Healthcare news, CEO John Anthony Martins purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, August 24th. The stock was purchased at an average price of $25.24 per share, with a total value of $100,960.00. Following the acquisition, the chief executive officer now owns 52,039 shares in the company, valued at $1,313,464.36. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director W Larry Cash acquired 1,500 shares of Cross Country Healthcare stock in a transaction that occurred on Tuesday, August 30th. The stock was purchased at an average cost of $25.60 per share, for a total transaction of $38,400.00. Following the completion of the transaction, the director now directly owns 177,899 shares in the company, valued at $4,554,214.40. The disclosure for this purchase can be found here. Insiders own 5.00% of the company’s stock.

Hedge Funds Weigh In On Cross Country Healthcare

Institutional investors have recently modified their holdings of the stock. US Bancorp DE purchased a new position in shares of Cross Country Healthcare during the first quarter worth approximately $27,000. Point72 Hong Kong Ltd purchased a new position in shares of Cross Country Healthcare during the first quarter worth approximately $35,000. Gladius Capital Management LP purchased a new position in shares of Cross Country Healthcare during the second quarter worth approximately $60,000. Advisor Group Holdings Inc. increased its position in shares of Cross Country Healthcare by 492.6% during the fourth quarter. Advisor Group Holdings Inc. now owns 2,963 shares of the business services provider’s stock worth $82,000 after acquiring an additional 2,463 shares during the period. Finally, Captrust Financial Advisors increased its position in shares of Cross Country Healthcare by 26.4% during the first quarter. Captrust Financial Advisors now owns 3,074 shares of the business services provider’s stock worth $67,000 after acquiring an additional 642 shares during the period. 95.25% of the stock is owned by hedge funds and other institutional investors.

About Cross Country Healthcare

(Get Rating)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services.

Further Reading

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.